Hershey’s CEO told stockholders that GLP-1 side effects are creating a ‘strong demand for gum.’
Ozempic Breath Is on the Rise—and So Is This Unlikely Winner
Get alerts for these topics
Hershey’s CEO told stockholders that GLP-1 side effects are creating a ‘strong demand for gum.’